Loading...

SeqLL Inc.

SQL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.60
$-0.16(-2.38%)

SeqLL Inc. (SQL) Stock Overview

Explore SeqLL Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.0/100

Key Financials

Market Cap2.5M
P/E Ratio-2.51
EPS (TTM)$-16.40
ROE10.89%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$3.80
1 Year Target$2.23

SQL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SeqLL Inc. (SQL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.51 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;